In the last 12 months, insiders at BIO-RAD LABORATORIES, INC. ($BIO) filed 430 transactions with the SEC: 0 open-market purchases totaling $0 and 19 sales totaling $6,950,007. Net insider sentiment: net selling.
BIO-RAD LABORATORIES, INC. operates in the Laboratory analytical instruments industry (Industrial Applications and Services sector).
Most Active Insiders
- SCHWARTZ NORMAN D (Chairman, President, and CEO) — 48 transactions totaling $40,368,764
- ERNST TIMOTHY S (EVP, General Counsel & Sec) — 32 transactions totaling $4,589,128
- Crowley Michael (EVP, GBL Commercial Operations) — 42 transactions totaling $4,107,577
- Last Andrew J. (EVP, Chief Operating Officer) — 32 transactions totaling $3,224,380
- SCHWARTZ NORMAN D (Chairman & CEO) — 11 transactions totaling $1,370,079
View all SEC Filings for BIO-RAD LABORATORIES, INC. (BIO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 6, 2025 | BARRY JAMES | EVP, President, LSG | S | Bio-Rad A Common Stock | 700 | $306.18 | 509.6820 | 27,359,000 | 57.86% | 0.00% |
| Oct. 24, 2025 | DiVincenzo Jonathan P. | President & COO | M | Bio-Rad A Common Stock | 1869 | $0.00 | 1,869.0000 | 27,359,000 | 9999.99% | 0.01% |
| Oct. 24, 2025 | DiVincenzo Jonathan P. | President & COO | F | Bio-Rad A Common Stock | 950 | $339.75 | 919.0000 | 27,359,000 | 50.83% | 0.00% |
| Oct. 24, 2025 | DiVincenzo Jonathan P. | President & COO | M | Restricted Stock Units | 1869 | $0.00 | 5,609.0000 | 27,359,000 | 24.99% | 0.01% |
| Oct. 20, 2025 | EVRAN SEDAT | EVP, Global Supply Chain | F | Bio-Rad A Common Stock | 335 | $321.90 | 2,232.8470 | 27,359,000 | 13.05% | 0.00% |
| Oct. 20, 2025 | EVRAN SEDAT | EVP, Global Supply Chain | M | Bio-Rad A Common Stock | 1044 | $0.00 | 2,567.8470 | 27,359,000 | 68.51% | 0.00% |
| Oct. 20, 2025 | EVRAN SEDAT | EVP, Global Supply Chain | M | Restricted Stock Units | 1044 | $0.00 | 2,088.0000 | 27,359,000 | 33.33% | 0.00% |
| Sept. 6, 2025 | BARRY JAMES | EVP, President, LSG | F | Bio-Rad A Common Stock | 378 | $295.43 | 1,209.5550 | 28,214,000 | 23.81% | 0.00% |
| Sept. 5, 2025 | BARRY JAMES | EVP, President, LSG | A | Restricted Stock Units | 4110 | $0.00 | 4,110.0000 | 28,214,000 | 9999.99% | 0.01% |
| Sept. 6, 2025 | BARRY JAMES | EVP, President, LSG | M | Restricted Stock Units | 1056 | $0.00 | 3,168.0000 | 28,214,000 | 25.00% | 0.00% |
| Sept. 6, 2025 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 92 | $0.00 | 1,489.0000 | 28,214,000 | 6.59% | 0.00% |
| Sept. 5, 2025 | Mehta Rajat | EVP, GBL Commercial Operations | A | Restricted Stock Units | 5480 | $0.00 | 5,480.0000 | 28,214,000 | 9999.99% | 0.02% |
| Sept. 5, 2025 | Mehta Rajat | EVP, GBL Commercial Operations | A | Restricted Stock Units | 1827 | $0.00 | 1,827.0000 | 28,214,000 | 9999.99% | 0.01% |
| Sept. 6, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | M | Restricted Stock Units | 3455 | $0.00 | 10,367.0000 | 28,214,000 | 25.00% | 0.01% |
| Sept. 5, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | A | Restricted Stock Units | 16439 | $0.00 | 16,439.0000 | 28,214,000 | 9999.99% | 0.06% |
| Sept. 6, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | F | Bio-Rad A Common Stock | 1528 | $295.43 | 443,434.0000 | 28,214,000 | 0.34% | 0.01% |
| Sept. 6, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | M | Bio-Rad A Common Stock | 3455 | $0.00 | 444,962.0000 | 28,214,000 | 0.78% | 0.01% |
| Sept. 6, 2025 | ENLOE COURTNEY C | EVP, General Counsel & Sec | M | Restricted Stock Units | 768 | $0.00 | 2,304.0000 | 28,214,000 | 25.00% | 0.00% |
| Sept. 5, 2025 | ENLOE COURTNEY C | EVP, General Counsel & Sec | A | Restricted Stock Units | 2740 | $0.00 | 2,740.0000 | 28,214,000 | 9999.99% | 0.01% |
| Sept. 6, 2025 | ENLOE COURTNEY C | EVP, General Counsel & Sec | F | Bio-Rad A Common Stock | 275 | $295.43 | 628.9910 | 28,214,000 | 30.42% | 0.00% |
| Sept. 6, 2025 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 33 | $295.43 | 1,456.0000 | 28,214,000 | 2.22% | 0.00% |
| Sept. 5, 2025 | Allison Schwartz | Director | A | Restricted Stock Units | 914 | $0.00 | 914.0000 | 28,214,000 | 9999.99% | 0.00% |
| Sept. 6, 2025 | Allison Schwartz | Director | M | Restricted Stock Units | 92 | $0.00 | 277.0000 | 28,214,000 | 24.93% | 0.00% |
| Sept. 5, 2025 | DiVincenzo Jonathan P. | President & COO | A | Restricted Stock Units | 6850 | $0.00 | 6,850.0000 | 28,214,000 | 9999.99% | 0.02% |
| Sept. 6, 2025 | ENGELHARDT EVA ANETTE | EVP, President, CDG | M | Bio-Rad A Common Stock | 1152 | $0.00 | 1,309.0000 | 28,214,000 | 733.76% | 0.00% |
| Sept. 6, 2025 | ENGELHARDT EVA ANETTE | EVP, President, CDG | F | Bio-Rad A Common Stock | 413 | $295.43 | 896.0000 | 28,214,000 | 31.55% | 0.00% |
| Sept. 5, 2025 | ENGELHARDT EVA ANETTE | EVP, President, CDG | A | Restricted Stock Units | 4110 | $0.00 | 4,110.0000 | 28,214,000 | 9999.99% | 0.01% |
| Sept. 6, 2025 | ENGELHARDT EVA ANETTE | EVP, President, CDG | M | Restricted Stock Units | 1152 | $0.00 | 3,456.0000 | 28,214,000 | 25.00% | 0.00% |
| Sept. 6, 2025 | ENLOE COURTNEY C | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 768 | $0.00 | 903.9910 | 28,214,000 | 564.74% | 0.00% |
| Sept. 6, 2025 | EVRAN SEDAT | EVP, Global Supply Chain | M | Bio-Rad A Common Stock | 864 | $0.00 | 1,800.8470 | 28,214,000 | 92.22% | 0.00% |
| Sept. 5, 2025 | EVRAN SEDAT | EVP, Global Supply Chain | A | Restricted Stock Units | 4110 | $0.00 | 4,110.0000 | 28,214,000 | 9999.99% | 0.01% |
| Sept. 6, 2025 | EVRAN SEDAT | EVP, Global Supply Chain | M | Restricted Stock Units | 864 | $0.00 | 2,592.0000 | 28,214,000 | 25.00% | 0.00% |
| Sept. 6, 2025 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | M | Bio-Rad A Common Stock | 1535 | $0.00 | 2,393.6590 | 28,214,000 | 178.77% | 0.01% |
| Sept. 6, 2025 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | F | Bio-Rad A Common Stock | 550 | $295.43 | 1,843.6590 | 28,214,000 | 22.98% | 0.00% |
| Sept. 6, 2025 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | M | Restricted Stock Units | 1535 | $0.00 | 4,608.0000 | 28,214,000 | 24.99% | 0.01% |
| Sept. 5, 2025 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | A | Restricted Stock Units | 5480 | $0.00 | 5,480.0000 | 28,214,000 | 9999.99% | 0.02% |
| Sept. 6, 2025 | EVRAN SEDAT | EVP, Global Supply Chain | F | Bio-Rad A Common Stock | 277 | $295.43 | 1,523.8470 | 28,214,000 | 15.38% | 0.00% |
| Sept. 6, 2025 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 576 | $0.00 | 19,759.0000 | 28,214,000 | 3.00% | 0.00% |
| Sept. 6, 2025 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 209 | $295.43 | 19,550.0000 | 28,214,000 | 1.06% | 0.00% |
| Sept. 5, 2025 | COREY COLLEEN | EVP, Global Human Resources | A | Restricted Stock Units | 2740 | $0.00 | 2,740.0000 | 28,214,000 | 9999.99% | 0.01% |
| Sept. 6, 2025 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 576 | $0.00 | 1,728.0000 | 28,214,000 | 25.00% | 0.00% |
| Sept. 6, 2025 | BARRY JAMES | EVP, President, LSG | M | Bio-Rad A Common Stock | 1056 | $0.00 | 1,587.5550 | 28,214,000 | 198.66% | 0.00% |
| Sept. 1, 2025 | BARRY JAMES | EVP, President, LSG | M | Restricted Stock Units | 250 | $0.00 | 502.0000 | 28,214,000 | 33.24% | 0.00% |
| Sept. 1, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | M | Restricted Stock Units | 3005 | $0.00 | 6,010.0000 | 28,214,000 | 33.33% | 0.01% |
| Sept. 1, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | M | Restricted Stock Units | 2082 | $0.00 | 2,082.0000 | 28,214,000 | 50.00% | 0.01% |
| Sept. 1, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | M | Restricted Stock Units | 1266 | $0.00 | 0.0000 | 28,214,000 | 100.00% | 0.00% |
| Sept. 1, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | F | Bio-Rad A Common Stock | 3084 | $297.88 | 441,507.0000 | 28,214,000 | 0.69% | 0.01% |
| Sept. 1, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | M | Bio-Rad A Common Stock | 6353 | $0.00 | 444,591.0000 | 28,214,000 | 1.45% | 0.02% |
| Sept. 1, 2025 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 501 | $0.00 | 1,002.0000 | 28,214,000 | 33.33% | 0.00% |
| Sept. 1, 2025 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 347 | $0.00 | 347.0000 | 28,214,000 | 50.00% | 0.00% |
| Sept. 1, 2025 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 254 | $0.00 | 0.0000 | 28,214,000 | 100.00% | 0.00% |
| Sept. 1, 2025 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 398 | $297.88 | 19,183.0000 | 28,214,000 | 2.03% | 0.00% |
| Sept. 1, 2025 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 1102 | $0.00 | 19,581.0000 | 28,214,000 | 5.96% | 0.00% |
| Sept. 1, 2025 | BARRY JAMES | EVP, President, LSG | M | Restricted Stock Units | 174 | $0.00 | 174.0000 | 28,214,000 | 50.00% | 0.00% |
| Sept. 1, 2025 | BARRY JAMES | EVP, President, LSG | M | Restricted Stock Units | 178 | $0.00 | 0.0000 | 28,214,000 | 100.00% | 0.00% |
| Sept. 1, 2025 | BARRY JAMES | EVP, President, LSG | F | Bio-Rad A Common Stock | 217 | $297.88 | 531.5550 | 28,214,000 | 28.99% | 0.00% |
| Sept. 1, 2025 | BARRY JAMES | EVP, President, LSG | M | Bio-Rad A Common Stock | 602 | $0.00 | 748.5550 | 28,214,000 | 410.77% | 0.00% |
| Sept. 1, 2025 | Allison Schwartz | Director | M | Restricted Stock Units | 74 | $0.00 | 150.0000 | 28,214,000 | 33.04% | 0.00% |
| Sept. 1, 2025 | Allison Schwartz | Director | M | Restricted Stock Units | 42 | $0.00 | 42.0000 | 28,214,000 | 50.00% | 0.00% |
| Sept. 1, 2025 | Allison Schwartz | Director | M | Restricted Stock Units | 31 | $0.00 | 0.0000 | 28,214,000 | 100.00% | 0.00% |
| Sept. 1, 2025 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 55 | $297.88 | 1,397.0000 | 28,214,000 | 3.79% | 0.00% |
| Sept. 1, 2025 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 147 | $0.00 | 1,452.0000 | 28,214,000 | 11.26% | 0.00% |
| July 25, 2025 | ENGELHARDT EVA ANETTE | EVP, President, CDG | M | Restricted Stock Units | 245 | $0.00 | 738.0000 | 28,214,000 | 24.92% | 0.00% |
| July 25, 2025 | ENGELHARDT EVA ANETTE | EVP, President, CDG | F | Bio-Rad A Common Stock | 88 | $264.19 | 157.0000 | 28,214,000 | 35.92% | 0.00% |
| July 25, 2025 | ENGELHARDT EVA ANETTE | EVP, President, CDG | M | Bio-Rad A Common Stock | 245 | $0.00 | 245.0000 | 28,214,000 | 9999.99% | 0.00% |
| April 24, 2025 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | F | Bio-Rad A Common Stock | 386 | $249.74 | 845.3840 | 28,214,000 | 31.35% | 0.00% |
| April 24, 2025 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | M | Bio-Rad A Common Stock | 1077 | $0.00 | 1,231.3840 | 28,214,000 | 697.61% | 0.00% |
| April 24, 2025 | ENLOE COURTNEY C | EVP, General Counsel & Sec | F | Bio-Rad A Common Stock | 67 | $249.74 | 129.3930 | 28,214,000 | 34.12% | 0.00% |
| April 24, 2025 | ENLOE COURTNEY C | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 186 | $0.00 | 196.3930 | 28,214,000 | 1789.67% | 0.00% |
| April 24, 2025 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | M | Restricted Stock Units | 1077 | $0.00 | 3,234.0000 | 28,214,000 | 24.98% | 0.00% |
| April 24, 2025 | ENLOE COURTNEY C | EVP, General Counsel & Sec | M | Restricted Stock Units | 186 | $0.00 | 558.0000 | 28,214,000 | 25.00% | 0.00% |
| April 22, 2025 | EDWARDS JEFFREY L | Director | M | Restricted Stock Units | 308 | $0.00 | 0.0000 | 28,214,000 | 100.00% | 0.00% |
| April 22, 2025 | EDWARDS JEFFREY L | Director | M | Bio-Rad A Common Stock | 308 | $0.00 | 308.0000 | 28,214,000 | 9999.99% | 0.00% |
| April 22, 2025 | HINCKLEY GREGORY K | Director | M | Restricted Stock Units | 308 | $0.00 | 0.0000 | 28,214,000 | 100.00% | 0.00% |
| April 22, 2025 | HINCKLEY GREGORY K | Director | A | Restricted Stock Units | 407 | $0.00 | 407.0000 | 28,214,000 | 9999.99% | 0.00% |
| April 22, 2025 | HINCKLEY GREGORY K | Director | M | Bio-Rad A Common Stock | 308 | $0.00 | 308.0000 | 28,214,000 | 9999.99% | 0.00% |
| April 22, 2025 | PEI MELINDA LITHERLAND | Director | M | Restricted Stock Units | 308 | $0.00 | 0.0000 | 28,214,000 | 100.00% | 0.00% |
| April 22, 2025 | PEI MELINDA LITHERLAND | Director | A | Restricted Stock Units | 407 | $0.00 | 407.0000 | 28,214,000 | 9999.99% | 0.00% |
| April 22, 2025 | PEI MELINDA LITHERLAND | Director | M | Bio-Rad A Common Stock | 308 | $0.00 | 308.0000 | 28,214,000 | 9999.99% | 0.00% |
| April 22, 2025 | PINKSTON ARNOLD A | Director | M | Restricted Stock Units | 308 | $0.00 | 0.0000 | 28,214,000 | 100.00% | 0.00% |
| April 22, 2025 | PINKSTON ARNOLD A | Director | A | Restricted Stock Units | 407 | $0.00 | 407.0000 | 28,214,000 | 9999.99% | 0.00% |
| April 22, 2025 | PINKSTON ARNOLD A | Director | M | Bio-Rad A Common Stock | 308 | $0.00 | 308.0000 | 28,214,000 | 9999.99% | 0.00% |
| April 22, 2025 | EDWARDS JEFFREY L | Director | A | Restricted Stock Units | 407 | $0.00 | 407.0000 | 28,214,000 | 9999.99% | 0.00% |
| March 14, 2025 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 3000 | $159.32 | 11,171.0000 | 28,214,000 | 36.72% | 0.01% |
| March 14, 2025 | Crowley Michael | EVP, GBL Commercial Operations | S | Bio-Rad A Common Stock | 3000 | $247.06 | 8,171.0000 | 28,214,000 | 26.86% | 0.01% |
| March 14, 2025 | Crowley Michael | EVP, GBL Commercial Operations | M | Non-Qualified Stock Option (right to buy) | 3000 | $0.00 | 0.0000 | 28,214,000 | 100.00% | 0.01% |
| March 3, 2025 | ENGELHARDT EVA ANETTE | EVP, President, CDG | A | Non-Qualified Stock Option (right to buy) | 2918 | $0.00 | 2,918.0000 | 28,214,000 | 9999.99% | 0.01% |
| March 3, 2025 | SCHWARTZ NORMAN D | Chairman & CEO | A | Non-Qualified Stock Option (right to buy) | 11671 | $0.00 | 11,671.0000 | 28,214,000 | 9999.99% | 0.04% |
| March 3, 2025 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 3891 | $0.00 | 3,891.0000 | 28,214,000 | 9999.99% | 0.01% |
| March 3, 2025 | BARRY JAMES | EVP, President, LSG | A | Non-Qualified Stock Option (right to buy) | 2918 | $0.00 | 2,918.0000 | 28,214,000 | 9999.99% | 0.01% |
| March 3, 2025 | ENLOE COURTNEY C | EVP, General Counsel & Sec | A | Non-Qualified Stock Option (right to buy) | 1946 | $0.00 | 1,946.0000 | 28,214,000 | 9999.99% | 0.01% |
| March 3, 2025 | COREY COLLEEN | EVP, Global Human Resources | A | Non-Qualified Stock Option (right to buy) | 1946 | $0.00 | 1,946.0000 | 28,214,000 | 9999.99% | 0.01% |
| March 3, 2025 | EVRAN SEDAT | EVP, Global Supply Chain | A | Non-Qualified Stock Option (right to buy) | 2918 | $0.00 | 2,918.0000 | 28,214,000 | 9999.99% | 0.01% |
| March 3, 2025 | DiVincenzo Jonathan P. | President & COO | A | Non-Qualified Stock Option (right to buy) | 4863 | $0.00 | 4,863.0000 | 28,214,000 | 9999.99% | 0.02% |
| Oct. 24, 2024 | DiVincenzo Jonathan P. | President & COO | A | Restricted Stock Units | 7478 | $0.00 | 7,478.0000 | 28,286,000 | 9999.99% | 0.03% |
| Oct. 20, 2024 | EVRAN SEDAT | EVP, Global Supply Chain | M | Restricted Stock Units | 1044 | $0.00 | 3,132.0000 | 28,286,000 | 25.00% | 0.00% |
| Oct. 20, 2024 | EVRAN SEDAT | EVP, Global Supply Chain | F | Bio-Rad A Common Stock | 335 | $346.37 | 853.1400 | 28,286,000 | 28.20% | 0.00% |
| Oct. 20, 2024 | EVRAN SEDAT | EVP, Global Supply Chain | M | Bio-Rad A Common Stock | 1044 | $0.00 | 1,188.1400 | 28,286,000 | 724.30% | 0.00% |
| Sept. 6, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 3000 | $299.24 | 10,559.4501 | 29,209,000 | 39.69% | 0.01% |
| Sept. 6, 2024 | Last Andrew J. | EVP, Chief Operating Officer | S | Bio-Rad A Common Stock | 3000 | $329.94 | 7,559.4501 | 29,209,000 | 28.41% | 0.01% |
| Sept. 6, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Non-Qualified Stock Option (right to buy) | 3000 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.01% |
| Sept. 6, 2024 | Allison Schwartz | Director | A | Restricted Stock Units | 369 | $0.00 | 369.0000 | 29,209,000 | 9999.99% | 0.00% |
| Sept. 6, 2024 | COREY COLLEEN | EVP, Global Human Resources | A | Restricted Stock Units | 2304 | $0.00 | 2,304.0000 | 29,209,000 | 9999.99% | 0.01% |
| Sept. 6, 2024 | BARRY JAMES | EVP, President, LSG | A | Restricted Stock Units | 4224 | $0.00 | 4,224.0000 | 29,209,000 | 9999.99% | 0.01% |
| Sept. 6, 2024 | Crowley Michael | EVP, GBL Commercial Operations | A | Restricted Stock Units | 3456 | $0.00 | 3,456.0000 | 29,209,000 | 9999.99% | 0.01% |
| Sept. 6, 2024 | HINCKLEY GREGORY K | Director | A | Restricted Stock Units | 308 | $0.00 | 308.0000 | 29,209,000 | 9999.99% | 0.00% |
| Sept. 6, 2024 | PINKSTON ARNOLD A | Director | A | Restricted Stock Units | 308 | $0.00 | 308.0000 | 29,209,000 | 9999.99% | 0.00% |
| Sept. 6, 2024 | PEI MELINDA LITHERLAND | Director | A | Restricted Stock Units | 308 | $0.00 | 308.0000 | 29,209,000 | 9999.99% | 0.00% |
| Sept. 6, 2024 | EDWARDS JEFFREY L | Director | A | Restricted Stock Units | 308 | $0.00 | 308.0000 | 29,209,000 | 9999.99% | 0.00% |
| Sept. 6, 2024 | ENLOE COURTNEY C | EVP, General Counsel & Sec | A | Restricted Stock Units | 3072 | $0.00 | 3,072.0000 | 29,209,000 | 9999.99% | 0.01% |
| Sept. 6, 2024 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | A | Restricted Stock Units | 6143 | $0.00 | 6,143.0000 | 29,209,000 | 9999.99% | 0.02% |
| Sept. 6, 2024 | EVRAN SEDAT | EVP, Global Supply Chain | A | Restricted Stock Units | 3456 | $0.00 | 3,456.0000 | 29,209,000 | 9999.99% | 0.01% |
| Sept. 6, 2024 | SCHWARTZ NORMAN D | Chairman & CEO | A | Restricted Stock Units | 13822 | $0.00 | 13,822.0000 | 29,209,000 | 9999.99% | 0.05% |
| Sept. 6, 2024 | ENGELHARDT EVA ANETTE | EVP, President, CDG | A | Restricted Stock Units | 4608 | $0.00 | 4,608.0000 | 29,209,000 | 9999.99% | 0.02% |
| Sept. 1, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 751 | $0.00 | 7,324.0000 | 29,209,000 | 11.43% | 0.00% |
| Sept. 1, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 520 | $0.00 | 7,576.0000 | 29,209,000 | 7.37% | 0.00% |
| Sept. 3, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 557 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 2, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 434 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 1, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 405 | $0.00 | 406.0000 | 29,209,000 | 49.94% | 0.00% |
| Sept. 1, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 520 | $0.00 | 1,042.0000 | 29,209,000 | 33.29% | 0.00% |
| Sept. 1, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 751 | $0.00 | 2,254.0000 | 29,209,000 | 24.99% | 0.00% |
| Sept. 3, 2024 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 283 | $334.31 | 8,171.0000 | 29,209,000 | 3.35% | 0.00% |
| Sept. 3, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 557 | $0.00 | 8,454.0000 | 29,209,000 | 7.05% | 0.00% |
| Sept. 2, 2024 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 155 | $337.32 | 7,897.0000 | 29,209,000 | 1.92% | 0.00% |
| Sept. 2, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 434 | $0.00 | 8,052.0000 | 29,209,000 | 5.70% | 0.00% |
| Sept. 1, 2024 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 145 | $337.32 | 7,618.0000 | 29,209,000 | 1.87% | 0.00% |
| Sept. 1, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 405 | $0.00 | 7,763.0000 | 29,209,000 | 5.50% | 0.00% |
| Sept. 1, 2024 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 218 | $337.32 | 7,358.0000 | 29,209,000 | 2.88% | 0.00% |
| Sept. 1, 2024 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 268 | $337.32 | 7,056.0000 | 29,209,000 | 3.66% | 0.00% |
| Sept. 1, 2024 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 31 | $0.00 | 1,268.0000 | 29,209,000 | 2.51% | 0.00% |
| Sept. 1, 2024 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 15 | $337.32 | 1,253.0000 | 29,209,000 | 1.18% | 0.00% |
| Sept. 2, 2024 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 44 | $0.00 | 1,297.0000 | 29,209,000 | 3.51% | 0.00% |
| Sept. 2, 2024 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 21 | $337.32 | 1,276.0000 | 29,209,000 | 1.62% | 0.00% |
| Sept. 3, 2024 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 56 | $0.00 | 1,332.0000 | 29,209,000 | 4.39% | 0.00% |
| Sept. 3, 2024 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 27 | $334.31 | 1,305.0000 | 29,209,000 | 2.03% | 0.00% |
| Sept. 1, 2024 | Allison Schwartz | Director | M | Restricted Stock Units | 74 | $0.00 | 224.0000 | 29,209,000 | 24.83% | 0.00% |
| Sept. 1, 2024 | Allison Schwartz | Director | M | Restricted Stock Units | 42 | $0.00 | 84.0000 | 29,209,000 | 33.33% | 0.00% |
| Sept. 1, 2024 | Allison Schwartz | Director | M | Restricted Stock Units | 31 | $0.00 | 31.0000 | 29,209,000 | 50.00% | 0.00% |
| Sept. 2, 2024 | Allison Schwartz | Director | M | Restricted Stock Units | 44 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 3, 2024 | Allison Schwartz | Director | M | Restricted Stock Units | 56 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 1, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 347 | $0.00 | 694.0000 | 29,209,000 | 33.33% | 0.00% |
| Sept. 1, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 500 | $0.00 | 1,503.0000 | 29,209,000 | 24.96% | 0.00% |
| Sept. 3, 2024 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 177 | $334.31 | 18,479.0000 | 29,209,000 | 0.95% | 0.00% |
| Sept. 3, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 495 | $0.00 | 18,656.0000 | 29,209,000 | 2.73% | 0.00% |
| Sept. 2, 2024 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 129 | $337.32 | 18,161.0000 | 29,209,000 | 0.71% | 0.00% |
| Sept. 2, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 361 | $0.00 | 18,290.0000 | 29,209,000 | 2.01% | 0.00% |
| Sept. 1, 2024 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 91 | $337.32 | 17,929.0000 | 29,209,000 | 0.50% | 0.00% |
| Sept. 1, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 253 | $0.00 | 18,020.0000 | 29,209,000 | 1.42% | 0.00% |
| Sept. 1, 2024 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 124 | $337.32 | 17,767.0000 | 29,209,000 | 0.69% | 0.00% |
| Sept. 1, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 347 | $0.00 | 17,891.0000 | 29,209,000 | 1.98% | 0.00% |
| Sept. 1, 2024 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 179 | $337.32 | 17,544.0000 | 29,209,000 | 1.01% | 0.00% |
| Sept. 1, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 500 | $0.00 | 17,723.0000 | 29,209,000 | 2.90% | 0.00% |
| Sept. 3, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 2320 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.01% |
| Sept. 2, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 1805 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.01% |
| Sept. 1, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 1266 | $0.00 | 1,266.0000 | 29,209,000 | 50.00% | 0.00% |
| Sept. 1, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 2081 | $0.00 | 4,164.0000 | 29,209,000 | 33.32% | 0.01% |
| Sept. 1, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 3005 | $0.00 | 9,015.0000 | 29,209,000 | 25.00% | 0.01% |
| Sept. 3, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 1241 | $334.31 | 438,238.0000 | 29,209,000 | 0.28% | 0.00% |
| Sept. 3, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 2320 | $0.00 | 439,479.0000 | 29,209,000 | 0.53% | 0.01% |
| Sept. 2, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 965 | $337.32 | 437,159.0000 | 29,209,000 | 0.22% | 0.00% |
| Sept. 2, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 1805 | $0.00 | 438,124.0000 | 29,209,000 | 0.41% | 0.01% |
| Sept. 1, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 545 | $337.32 | 436,319.0000 | 29,209,000 | 0.12% | 0.00% |
| Sept. 1, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 1266 | $0.00 | 436,864.0000 | 29,209,000 | 0.29% | 0.00% |
| Sept. 1, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 801 | $337.32 | 435,598.0000 | 29,209,000 | 0.18% | 0.00% |
| Sept. 1, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 2081 | $0.00 | 436,399.0000 | 29,209,000 | 0.48% | 0.01% |
| Sept. 1, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 1607 | $337.32 | 434,318.0000 | 29,209,000 | 0.37% | 0.01% |
| Sept. 1, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 3005 | $0.00 | 435,925.0000 | 29,209,000 | 0.69% | 0.01% |
| Sept. 1, 2024 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 35 | $337.32 | 1,215.0000 | 29,209,000 | 2.80% | 0.00% |
| Sept. 2, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 361 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 3, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 495 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 1, 2024 | BARRY JAMES | EVP, President, LSG | M | Bio-Rad A Common Stock | 250 | $0.00 | 326.5550 | 29,209,000 | 326.56% | 0.00% |
| Sept. 1, 2024 | BARRY JAMES | EVP, President, LSG | F | Bio-Rad A Common Stock | 90 | $337.32 | 236.5550 | 29,209,000 | 27.56% | 0.00% |
| Sept. 1, 2024 | BARRY JAMES | EVP, President, LSG | M | Bio-Rad A Common Stock | 173 | $0.00 | 409.5550 | 29,209,000 | 73.13% | 0.00% |
| Sept. 1, 2024 | BARRY JAMES | EVP, President, LSG | F | Bio-Rad A Common Stock | 62 | $337.32 | 347.5550 | 29,209,000 | 15.14% | 0.00% |
| Sept. 1, 2024 | BARRY JAMES | EVP, President, LSG | M | Bio-Rad A Common Stock | 177 | $0.00 | 524.5550 | 29,209,000 | 50.93% | 0.00% |
| Sept. 1, 2024 | BARRY JAMES | EVP, President, LSG | F | Bio-Rad A Common Stock | 64 | $337.32 | 460.5550 | 29,209,000 | 12.20% | 0.00% |
| Sept. 2, 2024 | BARRY JAMES | EVP, President, LSG | M | Bio-Rad A Common Stock | 265 | $0.00 | 725.5550 | 29,209,000 | 57.54% | 0.00% |
| Sept. 2, 2024 | BARRY JAMES | EVP, President, LSG | F | Bio-Rad A Common Stock | 95 | $337.32 | 630.5550 | 29,209,000 | 13.09% | 0.00% |
| Sept. 3, 2024 | BARRY JAMES | EVP, President, LSG | M | Bio-Rad A Common Stock | 217 | $0.00 | 847.5550 | 29,209,000 | 34.41% | 0.00% |
| Sept. 3, 2024 | BARRY JAMES | EVP, President, LSG | F | Bio-Rad A Common Stock | 78 | $334.31 | 769.5550 | 29,209,000 | 9.20% | 0.00% |
| Sept. 4, 2024 | BARRY JAMES | EVP, President, LSG | S | Bio-Rad A Common Stock | 623 | $330.49 | 146.5550 | 29,209,000 | 80.96% | 0.00% |
| Sept. 1, 2024 | BARRY JAMES | EVP, President, LSG | M | Restricted Stock Units | 250 | $0.00 | 752.0000 | 29,209,000 | 24.95% | 0.00% |
| Sept. 1, 2024 | BARRY JAMES | EVP, President, LSG | M | Restricted Stock Units | 173 | $0.00 | 348.0000 | 29,209,000 | 33.21% | 0.00% |
| Sept. 1, 2024 | BARRY JAMES | EVP, President, LSG | M | Restricted Stock Units | 177 | $0.00 | 178.0000 | 29,209,000 | 49.86% | 0.00% |
| Sept. 2, 2024 | BARRY JAMES | EVP, President, LSG | M | Restricted Stock Units | 265 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 3, 2024 | BARRY JAMES | EVP, President, LSG | M | Restricted Stock Units | 217 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 1, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 1252 | $0.00 | 7,010.4501 | 29,209,000 | 21.74% | 0.00% |
| Sept. 1, 2024 | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 635 | $337.32 | 6,375.4501 | 29,209,000 | 9.06% | 0.00% |
| Sept. 1, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 867 | $0.00 | 7,242.4501 | 29,209,000 | 13.60% | 0.00% |
| Sept. 1, 2024 | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 440 | $337.32 | 6,802.4501 | 29,209,000 | 6.08% | 0.00% |
| Sept. 1, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 633 | $0.00 | 7,435.4501 | 29,209,000 | 9.31% | 0.00% |
| Sept. 1, 2024 | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 321 | $337.32 | 7,114.4501 | 29,209,000 | 4.32% | 0.00% |
| Sept. 2, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 903 | $0.00 | 8,017.4501 | 29,209,000 | 12.69% | 0.00% |
| Sept. 2, 2024 | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 458 | $337.32 | 7,559.4501 | 29,209,000 | 5.71% | 0.00% |
| Sept. 1, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 1252 | $0.00 | 3,756.0000 | 29,209,000 | 25.00% | 0.00% |
| Sept. 1, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 867 | $0.00 | 1,735.0000 | 29,209,000 | 33.32% | 0.00% |
| Sept. 1, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 633 | $0.00 | 633.0000 | 29,209,000 | 50.00% | 0.00% |
| Sept. 2, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 903 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 1, 2024 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 74 | $0.00 | 1,250.0000 | 29,209,000 | 6.29% | 0.00% |
| Sept. 1, 2024 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 253 | $0.00 | 254.0000 | 29,209,000 | 49.90% | 0.00% |
| Sept. 1, 2024 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 42 | $0.00 | 1,257.0000 | 29,209,000 | 3.46% | 0.00% |
| Sept. 1, 2024 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 20 | $337.32 | 1,237.0000 | 29,209,000 | 1.59% | 0.00% |
| Aug. 26, 2024 | Allison Schwartz | Director | G | Bio-Rad B Common Stock | 57 | $0.00 | 3,996.0000 | 29,209,000 | 1.45% | 0.00% |
| Aug. 26, 2024 | SCHWARTZ ALICE N | Other | G | Bio-Rad A Common Stock | 3190 | $0.00 | 2,714,928.0000 | 29,209,000 | 0.12% | 0.01% |
| Aug. 26, 2024 | SCHWARTZ ALICE N | Other | G | Bio-Rad B Common Stock | 342 | $0.00 | 4,554,564.0000 | 29,209,000 | 0.01% | 0.00% |
| Aug. 26, 2024 | SCHWARTZ STEVEN D | TenPercentOwner | G | Bio-Rad B Common Stock | 57 | $0.00 | 4,098,294.0000 | 29,209,000 | 0.00% | 0.00% |
| Aug. 26, 2024 | SCHWARTZ STEVEN D | TenPercentOwner | G | Bio-Rad B Common Stock | 57 | $0.00 | 4,098,294.0000 | 29,209,000 | 0.00% | 0.00% |
| Aug. 26, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | G | Bio-Rad B Common Stock | 57 | $0.00 | 4,434,526.0000 | 29,209,000 | 0.00% | 0.00% |
| Aug. 26, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | G | Bio-Rad B Common Stock | 57 | $0.00 | 4,434,526.0000 | 29,209,000 | 0.00% | 0.00% |
| July 25, 2024 | ENGELHARDT EVA ANETTE | EVP, President, CDG | A | Restricted Stock Units | 983 | $0.00 | 983.0000 | 29,209,000 | 9999.99% | 0.00% |
| June 13, 2024 | Crowley Michael | EVP, GBL Commercial Operations | S | Bio-Rad A Common Stock | 369 | $281.91 | 6,573.0000 | 29,209,000 | 5.32% | 0.00% |
| May 3, 2023 | SCHWARTZ STEVEN D | TenPercentOwner | S | Bio-Rad A Common Stock | 320 | $463.86 | 363,644.0335 | 29,785,000 | 0.09% | 0.00% |
| April 29, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 1000 | $0.00 | 6,076.8881 | 29,209,000 | 19.70% | 0.00% |
| April 29, 2024 | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 1000 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| April 29, 2024 | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 357 | $277.11 | 5,719.8881 | 29,209,000 | 5.87% | 0.00% |
| April 24, 2024 | Lakkaraju Roop Kalyan | EVP, Chief Financial Officer | A | Restricted Stock Units | 4311 | $0.00 | 4,311.0000 | 29,209,000 | 9999.99% | 0.01% |
| April 24, 2024 | ENLOE COURTNEY C | EVP, General Counsel & Sec | A | Restricted Stock Units | 744 | $0.00 | 744.0000 | 29,209,000 | 9999.99% | 0.00% |
| March 8, 2024 | MAY SIMON | EVP, President, LSG | A | Non-Qualified Stock Option (right to buy) | 3535 | $0.00 | 3,535.0000 | 29,209,000 | 9999.99% | 0.01% |
| March 8, 2024 | COREY COLLEEN | EVP, Global Human Resources | A | Non-Qualified Stock Option (right to buy) | 2357 | $0.00 | 2,357.0000 | 29,209,000 | 9999.99% | 0.01% |
| March 8, 2024 | ERNST TIMOTHY S | EVP, General Counsel & Sec | A | Non-Qualified Stock Option (right to buy) | 2357 | $0.00 | 2,357.0000 | 29,209,000 | 9999.99% | 0.01% |
| March 8, 2024 | EVRAN SEDAT | EVP, Global Supply Chain | A | Non-Qualified Stock Option (right to buy) | 3535 | $0.00 | 3,535.0000 | 29,209,000 | 9999.99% | 0.01% |
| March 8, 2024 | Crowley Michael | EVP, GBL Commercial Operations | A | Non-Qualified Stock Option (right to buy) | 3535 | $0.00 | 3,535.0000 | 29,209,000 | 9999.99% | 0.01% |
| March 8, 2024 | SCHWARTZ NORMAN D | Chairman, President, and CEO | A | Non-Qualified Stock Option (right to buy) | 14137 | $0.00 | 14,137.0000 | 29,209,000 | 9999.99% | 0.05% |
| March 8, 2024 | Last Andrew J. | EVP, Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 5891 | $0.00 | 5,891.0000 | 29,209,000 | 9999.99% | 0.02% |
| Feb. 28, 2024 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 2500 | $326.15 | 5,897.4775 | 29,209,000 | 73.58% | 0.01% |
| Feb. 28, 2024 | ERNST TIMOTHY S | EVP, General Counsel & Sec | S | Bio-Rad A Common Stock | 2500 | $330.55 | 3,397.4775 | 29,209,000 | 42.39% | 0.01% |
| Feb. 28, 2024 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Non-Qualified Stock Option (right to buy) | 2500 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.01% |
| Feb. 27, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Non-Qualified Stock Option (right to buy) | 3000 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.01% |
| Feb. 27, 2024 | Crowley Michael | EVP, GBL Commercial Operations | S | Bio-Rad A Common Stock | 3000 | $336.00 | 6,942.0000 | 29,209,000 | 30.18% | 0.01% |
| Feb. 27, 2024 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 3000 | $215.98 | 9,942.0000 | 29,209,000 | 43.22% | 0.01% |
| Dec. 16, 2023 | WRIGHT DARA | EVP, President, CDG | M | Bio-Rad A Common Stock | 502 | $0.00 | 2,001.0776 | 29,785,000 | 33.49% | 0.00% |
| Dec. 16, 2023 | WRIGHT DARA | EVP, President, CDG | F | Bio-Rad A Common Stock | 174 | $306.12 | 1,827.0776 | 29,785,000 | 8.70% | 0.00% |
| Dec. 16, 2023 | WRIGHT DARA | EVP, President, CDG | M | Restricted Stock Units | 502 | $0.00 | 503.0000 | 29,785,000 | 49.95% | 0.00% |
| Dec. 5, 2023 | SCHWARTZ STEVEN D | TenPercentOwner | G | Bio-Rad B Common Stock | 49 | $0.00 | 4,098,180.0000 | 29,785,000 | 0.00% | 0.00% |
| Dec. 5, 2023 | SCHWARTZ STEVEN D | TenPercentOwner | G | Bio-Rad B Common Stock | 49 | $0.00 | 4,098,180.0000 | 29,785,000 | 0.00% | 0.00% |
| Dec. 12, 2023 | WRIGHT DARA | EVP, President, CDG | S | Bio-Rad A Common Stock | 1200 | $299.16 | 1,499.0776 | 29,785,000 | 44.46% | 0.00% |
| Dec. 5, 2023 | Allison Schwartz | Director | G | Bio-Rad B Common Stock | 49 | $0.00 | 3,939.0000 | 29,785,000 | 1.26% | 0.00% |
| Dec. 5, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | G | Bio-Rad B Common Stock | 49 | $0.00 | 4,434,412.0000 | 29,785,000 | 0.00% | 0.00% |
| Dec. 5, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | G | Bio-Rad B Common Stock | 49 | $0.00 | 4,434,412.0000 | 29,785,000 | 0.00% | 0.00% |
| Dec. 5, 2023 | SCHWARTZ ALICE N | Other | G | Bio-Rad A Common Stock | 3270 | $0.00 | 2,718,118.0000 | 29,785,000 | 0.12% | 0.01% |
| Dec. 5, 2023 | SCHWARTZ ALICE N | Other | G | Bio-Rad B Common Stock | 294 | $0.00 | 4,554,906.0000 | 29,785,000 | 0.01% | 0.00% |
| Nov. 28, 2023 | Crowley Michael | EVP, GBL Commercial Operations | S | Bio-Rad A Common Stock | 642 | $305.10 | 6,942.0000 | 29,785,000 | 8.47% | 0.00% |
| Nov. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad B Common Stock | 35000 | $119.80 | 4,453,254.0000 | 29,785,000 | 0.79% | 0.12% |
| Nov. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad B Common Stock | 25642 | $273.00 | 4,427,612.0000 | 29,785,000 | 0.58% | 0.09% |
| Nov. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad B Common Stock | 16000 | $139.56 | 4,443,612.0000 | 29,785,000 | 0.36% | 0.05% |
| Nov. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad B Common Stock | 12274 | $273.00 | 4,431,338.0000 | 29,785,000 | 0.28% | 0.04% |
| Nov. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad B Common Stock | 15000 | $159.32 | 4,446,338.0000 | 29,785,000 | 0.34% | 0.05% |
| Nov. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad B Common Stock | 12024 | $273.00 | 4,434,314.0000 | 29,785,000 | 0.27% | 0.04% |
| Nov. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Non-Qualified Stock Option (right to buy) | 35000 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.12% |
| Nov. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Non-Qualified Stock Option (right to buy) | 16000 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.05% |
| Nov. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Non-Qualified Stock Option (right to buy) | 15000 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.05% |
| Oct. 20, 2023 | EVRAN SEDAT | EVP, Global Supply Chain | A | Restricted Stock Units | 4176 | $0.00 | 4,176.0000 | 29,785,000 | 9999.99% | 0.01% |
| Sept. 1, 2023 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 867 | $0.00 | 4,660.6001 | 29,785,000 | 22.85% | 0.00% |
| Sept. 1, 2023 | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 430 | $394.60 | 4,230.6001 | 29,785,000 | 9.23% | 0.00% |
| Sept. 1, 2023 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 633 | $0.00 | 4,863.6001 | 29,785,000 | 14.96% | 0.00% |
| Sept. 1, 2023 | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 279 | $394.60 | 4,584.6001 | 29,785,000 | 5.74% | 0.00% |
| Sept. 2, 2023 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 903 | $0.00 | 5,487.6001 | 29,785,000 | 19.70% | 0.00% |
| Sept. 2, 2023 | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 448 | $394.60 | 5,039.6001 | 29,785,000 | 8.16% | 0.00% |
| Sept. 1, 2023 | Last Andrew J. | EVP, Chief Operating Officer | A | Restricted Stock Units | 5008 | $0.00 | 5,008.0000 | 29,785,000 | 9999.99% | 0.02% |
| Sept. 1, 2023 | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 867 | $0.00 | 2,602.0000 | 29,785,000 | 24.99% | 0.00% |
| Sept. 1, 2023 | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 633 | $0.00 | 1,266.0000 | 29,785,000 | 33.33% | 0.00% |
| Sept. 2, 2023 | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 903 | $0.00 | 903.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 1, 2023 | WRIGHT DARA | Executive Vice President | M | Bio-Rad A Common Stock | 520 | $0.00 | 2,314.8746 | 29,785,000 | 28.97% | 0.00% |
| Sept. 1, 2023 | WRIGHT DARA | Executive Vice President | F | Bio-Rad A Common Stock | 180 | $394.60 | 2,134.8746 | 29,785,000 | 7.78% | 0.00% |
| Sept. 1, 2023 | WRIGHT DARA | Executive Vice President | M | Bio-Rad A Common Stock | 405 | $0.00 | 2,539.8746 | 29,785,000 | 18.97% | 0.00% |
| Sept. 1, 2023 | WRIGHT DARA | Executive Vice President | F | Bio-Rad A Common Stock | 141 | $394.60 | 2,398.8746 | 29,785,000 | 5.55% | 0.00% |
| Sept. 2, 2023 | WRIGHT DARA | Executive Vice President | M | Bio-Rad A Common Stock | 433 | $0.00 | 2,831.8746 | 29,785,000 | 18.05% | 0.00% |
| Sept. 2, 2023 | WRIGHT DARA | Executive Vice President | F | Bio-Rad A Common Stock | 150 | $394.60 | 2,681.8746 | 29,785,000 | 5.30% | 0.00% |
| Sept. 1, 2023 | WRIGHT DARA | Executive Vice President | A | Restricted Stock Units | 3005 | $0.00 | 3,005.0000 | 29,785,000 | 9999.99% | 0.01% |
| Sept. 1, 2023 | WRIGHT DARA | Executive Vice President | M | Restricted Stock Units | 520 | $0.00 | 1,562.0000 | 29,785,000 | 24.98% | 0.00% |
| Sept. 1, 2023 | WRIGHT DARA | Executive Vice President | M | Restricted Stock Units | 405 | $0.00 | 811.0000 | 29,785,000 | 33.31% | 0.00% |
| Sept. 2, 2023 | WRIGHT DARA | Executive Vice President | M | Restricted Stock Units | 433 | $0.00 | 434.0000 | 29,785,000 | 49.94% | 0.00% |
| Sept. 1, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 347 | $0.00 | 2,762.7965 | 29,785,000 | 14.36% | 0.00% |
| Sept. 1, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | F | Bio-Rad A Common Stock | 173 | $394.60 | 2,589.7965 | 29,785,000 | 6.26% | 0.00% |
| Sept. 1, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 253 | $0.00 | 2,842.7965 | 29,785,000 | 9.77% | 0.00% |
| Sept. 1, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | F | Bio-Rad A Common Stock | 126 | $394.60 | 2,716.7965 | 29,785,000 | 4.43% | 0.00% |
| Sept. 2, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 361 | $0.00 | 3,077.7965 | 29,785,000 | 13.29% | 0.00% |
| Sept. 2, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | F | Bio-Rad A Common Stock | 179 | $394.60 | 2,898.7965 | 29,785,000 | 5.82% | 0.00% |
| Sept. 3, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 464 | $0.00 | 3,362.7965 | 29,785,000 | 16.01% | 0.00% |
| Sept. 3, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | F | Bio-Rad A Common Stock | 231 | $394.60 | 3,131.7965 | 29,785,000 | 6.87% | 0.00% |
| Sept. 4, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 500 | $0.00 | 3,631.7965 | 29,785,000 | 15.97% | 0.00% |
| Sept. 4, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | F | Bio-Rad A Common Stock | 248 | $394.60 | 3,383.7965 | 29,785,000 | 6.83% | 0.00% |
| Sept. 1, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | A | Restricted Stock Units | 2003 | $0.00 | 2,003.0000 | 29,785,000 | 9999.99% | 0.01% |
| Sept. 1, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Restricted Stock Units | 347 | $0.00 | 1,041.0000 | 29,785,000 | 25.00% | 0.00% |
| Sept. 1, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Restricted Stock Units | 253 | $0.00 | 507.0000 | 29,785,000 | 33.29% | 0.00% |
| Sept. 2, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Restricted Stock Units | 361 | $0.00 | 361.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 3, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Restricted Stock Units | 464 | $0.00 | 464.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 4, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Restricted Stock Units | 500 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.00% |
| Sept. 1, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | M | Bio-Rad A Common Stock | 173 | $0.00 | 196.3950 | 29,785,000 | 739.47% | 0.00% |
| Sept. 1, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | F | Bio-Rad A Common Stock | 60 | $394.60 | 136.3950 | 29,785,000 | 30.55% | 0.00% |
| Sept. 1, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | M | Bio-Rad A Common Stock | 169 | $0.00 | 305.3950 | 29,785,000 | 123.90% | 0.00% |
| Sept. 1, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | F | Bio-Rad A Common Stock | 59 | $394.60 | 246.3950 | 29,785,000 | 19.32% | 0.00% |
| Sept. 2, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | M | Bio-Rad A Common Stock | 241 | $0.00 | 487.3950 | 29,785,000 | 97.81% | 0.00% |
| Sept. 2, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | F | Bio-Rad A Common Stock | 84 | $394.60 | 403.3950 | 29,785,000 | 17.23% | 0.00% |
| Sept. 1, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | M | Restricted Stock Units | 173 | $0.00 | 521.0000 | 29,785,000 | 24.93% | 0.00% |
| Sept. 1, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | M | Restricted Stock Units | 169 | $0.00 | 338.0000 | 29,785,000 | 33.33% | 0.00% |
| Sept. 2, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | M | Restricted Stock Units | 241 | $0.00 | 241.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 1, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 520 | $0.00 | 6,560.0000 | 29,785,000 | 8.61% | 0.00% |
| Sept. 1, 2023 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 180 | $394.60 | 6,380.0000 | 29,785,000 | 2.74% | 0.00% |
| Sept. 1, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 405 | $0.00 | 6,785.0000 | 29,785,000 | 6.35% | 0.00% |
| Sept. 1, 2023 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 141 | $394.60 | 6,644.0000 | 29,785,000 | 2.08% | 0.00% |
| Sept. 2, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 433 | $0.00 | 7,077.0000 | 29,785,000 | 6.52% | 0.00% |
| Sept. 2, 2023 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 150 | $394.60 | 6,927.0000 | 29,785,000 | 2.12% | 0.00% |
| Sept. 3, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 557 | $0.00 | 7,484.0000 | 29,785,000 | 8.04% | 0.00% |
| Sept. 3, 2023 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 202 | $394.60 | 7,282.0000 | 29,785,000 | 2.70% | 0.00% |
| Sept. 4, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Bio-Rad A Common Stock | 600 | $0.00 | 7,882.0000 | 29,785,000 | 8.24% | 0.00% |
| Sept. 4, 2023 | Crowley Michael | EVP, GBL Commercial Operations | F | Bio-Rad A Common Stock | 298 | $394.60 | 7,584.0000 | 29,785,000 | 3.78% | 0.00% |
| Sept. 1, 2023 | Crowley Michael | EVP, GBL Commercial Operations | A | Restricted Stock Units | 3005 | $0.00 | 3,005.0000 | 29,785,000 | 9999.99% | 0.01% |
| Sept. 1, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 520 | $0.00 | 1,562.0000 | 29,785,000 | 24.98% | 0.00% |
| Sept. 1, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 405 | $0.00 | 811.0000 | 29,785,000 | 33.31% | 0.00% |
| Sept. 2, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 433 | $0.00 | 434.0000 | 29,785,000 | 49.94% | 0.00% |
| Sept. 3, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 557 | $0.00 | 557.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 4, 2023 | Crowley Michael | EVP, GBL Commercial Operations | M | Restricted Stock Units | 600 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.00% |
| Sept. 1, 2023 | Daskal Ilan | EVP, Chief Financial Officer | M | Bio-Rad A Common Stock | 694 | $0.00 | 2,206.2120 | 29,785,000 | 45.89% | 0.00% |
| Sept. 1, 2023 | Daskal Ilan | EVP, Chief Financial Officer | F | Bio-Rad A Common Stock | 240 | $394.60 | 1,966.2120 | 29,785,000 | 10.88% | 0.00% |
| Sept. 1, 2023 | Daskal Ilan | EVP, Chief Financial Officer | M | Bio-Rad A Common Stock | 456 | $0.00 | 2,422.2120 | 29,785,000 | 23.19% | 0.00% |
| Sept. 1, 2023 | Daskal Ilan | EVP, Chief Financial Officer | F | Bio-Rad A Common Stock | 209 | $394.60 | 2,213.2120 | 29,785,000 | 8.63% | 0.00% |
| Sept. 2, 2023 | Daskal Ilan | EVP, Chief Financial Officer | M | Bio-Rad A Common Stock | 542 | $0.00 | 2,755.2120 | 29,785,000 | 24.49% | 0.00% |
| Sept. 2, 2023 | Daskal Ilan | EVP, Chief Financial Officer | F | Bio-Rad A Common Stock | 269 | $394.60 | 2,486.2120 | 29,785,000 | 9.76% | 0.00% |
| Sept. 1, 2023 | Daskal Ilan | EVP, Chief Financial Officer | A | Restricted Stock Units | 4007 | $0.00 | 4,007.0000 | 29,785,000 | 9999.99% | 0.01% |
| Sept. 1, 2023 | Daskal Ilan | EVP, Chief Financial Officer | M | Restricted Stock Units | 694 | $0.00 | 2,082.0000 | 29,785,000 | 25.00% | 0.00% |
| Sept. 1, 2023 | Daskal Ilan | EVP, Chief Financial Officer | M | Restricted Stock Units | 456 | $0.00 | 912.0000 | 29,785,000 | 33.33% | 0.00% |
| Sept. 2, 2023 | Daskal Ilan | EVP, Chief Financial Officer | M | Restricted Stock Units | 542 | $0.00 | 542.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 1, 2023 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 41 | $0.00 | 1,068.0000 | 29,785,000 | 3.99% | 0.00% |
| Sept. 1, 2023 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 17 | $394.60 | 1,051.0000 | 29,785,000 | 1.59% | 0.00% |
| Sept. 1, 2023 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 30 | $0.00 | 1,081.0000 | 29,785,000 | 2.85% | 0.00% |
| Sept. 1, 2023 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 12 | $394.60 | 1,069.0000 | 29,785,000 | 1.11% | 0.00% |
| Sept. 2, 2023 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 44 | $0.00 | 1,113.0000 | 29,785,000 | 4.12% | 0.00% |
| Sept. 2, 2023 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 18 | $394.60 | 1,095.0000 | 29,785,000 | 1.62% | 0.00% |
| Sept. 3, 2023 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 56 | $0.00 | 1,151.0000 | 29,785,000 | 5.11% | 0.00% |
| Sept. 3, 2023 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 23 | $394.60 | 1,128.0000 | 29,785,000 | 2.00% | 0.00% |
| Sept. 4, 2023 | Allison Schwartz | Director | M | Bio-Rad A Common Stock | 82 | $0.00 | 1,210.0000 | 29,785,000 | 7.27% | 0.00% |
| Sept. 4, 2023 | Allison Schwartz | Director | F | Bio-Rad A Common Stock | 34 | $394.60 | 1,176.0000 | 29,785,000 | 2.81% | 0.00% |
| Sept. 1, 2023 | Allison Schwartz | Director | A | Restricted Stock Units | 298 | $0.00 | 298.0000 | 29,785,000 | 9999.99% | 0.00% |
| Sept. 1, 2023 | Allison Schwartz | Director | M | Restricted Stock Units | 41 | $0.00 | 126.0000 | 29,785,000 | 24.55% | 0.00% |
| Sept. 1, 2023 | Allison Schwartz | Director | M | Restricted Stock Units | 30 | $0.00 | 62.0000 | 29,785,000 | 32.61% | 0.00% |
| Sept. 2, 2023 | Allison Schwartz | Director | M | Restricted Stock Units | 44 | $0.00 | 44.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 3, 2023 | Allison Schwartz | Director | M | Restricted Stock Units | 56 | $0.00 | 56.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 4, 2023 | Allison Schwartz | Director | M | Restricted Stock Units | 82 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.00% |
| Sept. 1, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Bio-Rad A Common Stock | 520 | $0.00 | 10,961.0277 | 29,785,000 | 4.98% | 0.00% |
| Sept. 1, 2023 | Dahowski Diane | EVP, Global Supply Chain | F | Bio-Rad A Common Stock | 180 | $394.60 | 10,781.0277 | 29,785,000 | 1.64% | 0.00% |
| Sept. 1, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Bio-Rad A Common Stock | 329 | $0.00 | 11,110.0277 | 29,785,000 | 3.05% | 0.00% |
| Sept. 1, 2023 | Dahowski Diane | EVP, Global Supply Chain | F | Bio-Rad A Common Stock | 114 | $394.60 | 10,996.0277 | 29,785,000 | 1.03% | 0.00% |
| Sept. 2, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Bio-Rad A Common Stock | 361 | $0.00 | 11,357.0277 | 29,785,000 | 3.28% | 0.00% |
| Sept. 2, 2023 | Dahowski Diane | EVP, Global Supply Chain | F | Bio-Rad A Common Stock | 125 | $394.60 | 11,232.0277 | 29,785,000 | 1.10% | 0.00% |
| Sept. 3, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Bio-Rad A Common Stock | 495 | $0.00 | 11,727.0277 | 29,785,000 | 4.41% | 0.00% |
| Sept. 3, 2023 | Dahowski Diane | EVP, Global Supply Chain | F | Bio-Rad A Common Stock | 172 | $394.60 | 11,555.0277 | 29,785,000 | 1.47% | 0.00% |
| Sept. 4, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Bio-Rad A Common Stock | 600 | $0.00 | 12,155.0277 | 29,785,000 | 5.19% | 0.00% |
| Sept. 4, 2023 | Dahowski Diane | EVP, Global Supply Chain | F | Bio-Rad A Common Stock | 275 | $394.60 | 11,880.0277 | 29,785,000 | 2.26% | 0.00% |
| Sept. 1, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Restricted Stock Units | 520 | $0.00 | 1,562.0000 | 29,785,000 | 24.98% | 0.00% |
| Sept. 1, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Restricted Stock Units | 329 | $0.00 | 659.0000 | 29,785,000 | 33.30% | 0.00% |
| Sept. 2, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Restricted Stock Units | 361 | $0.00 | 361.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 3, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Restricted Stock Units | 495 | $0.00 | 495.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 4, 2023 | Dahowski Diane | EVP, Global Supply Chain | M | Restricted Stock Units | 600 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.00% |
| Sept. 1, 2023 | MAY SIMON | EVP, President, LSG | M | Bio-Rad A Common Stock | 520 | $0.00 | 2,126.9894 | 29,785,000 | 32.36% | 0.00% |
| Sept. 1, 2023 | MAY SIMON | EVP, President, LSG | F | Bio-Rad A Common Stock | 180 | $394.60 | 1,946.9894 | 29,785,000 | 8.46% | 0.00% |
| Sept. 1, 2023 | MAY SIMON | EVP, President, LSG | M | Bio-Rad A Common Stock | 371 | $0.00 | 2,317.9894 | 29,785,000 | 19.06% | 0.00% |
| Sept. 1, 2023 | MAY SIMON | EVP, President, LSG | F | Bio-Rad A Common Stock | 129 | $394.60 | 2,188.9894 | 29,785,000 | 5.57% | 0.00% |
| Sept. 2, 2023 | MAY SIMON | EVP, President, LSG | M | Bio-Rad A Common Stock | 409 | $0.00 | 2,597.9894 | 29,785,000 | 18.68% | 0.00% |
| Sept. 2, 2023 | MAY SIMON | EVP, President, LSG | F | Bio-Rad A Common Stock | 142 | $394.60 | 2,455.9894 | 29,785,000 | 5.47% | 0.00% |
| Sept. 3, 2023 | MAY SIMON | EVP, President, LSG | M | Bio-Rad A Common Stock | 526 | $0.00 | 2,981.9894 | 29,785,000 | 21.42% | 0.00% |
| Sept. 3, 2023 | MAY SIMON | EVP, President, LSG | F | Bio-Rad A Common Stock | 182 | $394.60 | 2,799.9894 | 29,785,000 | 6.10% | 0.00% |
| Sept. 4, 2023 | MAY SIMON | EVP, President, LSG | M | Bio-Rad A Common Stock | 600 | $0.00 | 3,399.9894 | 29,785,000 | 21.43% | 0.00% |
| Sept. 4, 2023 | MAY SIMON | EVP, President, LSG | F | Bio-Rad A Common Stock | 295 | $394.60 | 3,104.9894 | 29,785,000 | 8.68% | 0.00% |
| Sept. 1, 2023 | MAY SIMON | EVP, President, LSG | A | Restricted Stock Units | 3005 | $0.00 | 3,005.0000 | 29,785,000 | 9999.99% | 0.01% |
| Sept. 1, 2023 | MAY SIMON | EVP, President, LSG | M | Restricted Stock Units | 520 | $0.00 | 1,562.0000 | 29,785,000 | 24.98% | 0.00% |
| Sept. 1, 2023 | MAY SIMON | EVP, President, LSG | M | Restricted Stock Units | 371 | $0.00 | 744.0000 | 29,785,000 | 33.27% | 0.00% |
| Sept. 2, 2023 | MAY SIMON | EVP, President, LSG | M | Restricted Stock Units | 409 | $0.00 | 410.0000 | 29,785,000 | 49.94% | 0.00% |
| Sept. 3, 2023 | MAY SIMON | EVP, President, LSG | M | Restricted Stock Units | 526 | $0.00 | 526.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 4, 2023 | MAY SIMON | EVP, President, LSG | M | Restricted Stock Units | 600 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.00% |
| Sept. 1, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 347 | $0.00 | 16,227.0000 | 29,785,000 | 2.19% | 0.00% |
| Sept. 1, 2023 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 120 | $394.60 | 16,107.0000 | 29,785,000 | 0.74% | 0.00% |
| Sept. 1, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 253 | $0.00 | 16,360.0000 | 29,785,000 | 1.57% | 0.00% |
| Sept. 1, 2023 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 88 | $394.60 | 16,272.0000 | 29,785,000 | 0.54% | 0.00% |
| Sept. 2, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 361 | $0.00 | 16,633.0000 | 29,785,000 | 2.22% | 0.00% |
| Sept. 2, 2023 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 125 | $394.60 | 16,508.0000 | 29,785,000 | 0.75% | 0.00% |
| Sept. 3, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 495 | $0.00 | 17,003.0000 | 29,785,000 | 3.00% | 0.00% |
| Sept. 3, 2023 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 172 | $394.60 | 16,831.0000 | 29,785,000 | 1.01% | 0.00% |
| Sept. 4, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Bio-Rad A Common Stock | 600 | $0.00 | 17,431.0000 | 29,785,000 | 3.56% | 0.00% |
| Sept. 4, 2023 | COREY COLLEEN | EVP, Global Human Resources | F | Bio-Rad A Common Stock | 208 | $394.60 | 17,223.0000 | 29,785,000 | 1.19% | 0.00% |
| Sept. 1, 2023 | COREY COLLEEN | EVP, Global Human Resources | A | Restricted Stock Units | 2003 | $0.00 | 2,003.0000 | 29,785,000 | 9999.99% | 0.01% |
| Sept. 1, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 347 | $0.00 | 1,041.0000 | 29,785,000 | 25.00% | 0.00% |
| Sept. 1, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 253 | $0.00 | 507.0000 | 29,785,000 | 33.29% | 0.00% |
| Sept. 2, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 361 | $0.00 | 361.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 3, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 495 | $0.00 | 495.0000 | 29,785,000 | 50.00% | 0.00% |
| Sept. 4, 2023 | COREY COLLEEN | EVP, Global Human Resources | M | Restricted Stock Units | 600 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.00% |
| Sept. 1, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | A | Restricted Stock Units | 12020 | $0.00 | 12,020.0000 | 29,785,000 | 9999.99% | 0.04% |
| Aug. 30, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 2350 | $215.98 | 4,765.7965 | 29,785,000 | 97.28% | 0.01% |
| Aug. 30, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | S | Bio-Rad A Common Stock | 391 | $394.16 | 4,374.7965 | 29,785,000 | 8.20% | 0.00% |
| Aug. 30, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | S | Bio-Rad A Common Stock | 1582 | $395.76 | 2,792.7965 | 29,785,000 | 36.16% | 0.01% |
| Aug. 30, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | S | Bio-Rad A Common Stock | 377 | $396.44 | 2,415.7965 | 29,785,000 | 13.50% | 0.00% |
| Aug. 30, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Non-Qualified Stock Option (right to buy) | 2350 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.01% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 2081 | $0.00 | 429,925.0000 | 29,785,000 | 0.49% | 0.01% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 1032 | $381.78 | 428,893.0000 | 29,785,000 | 0.24% | 0.00% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 1266 | $0.00 | 430,159.0000 | 29,785,000 | 0.30% | 0.00% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 628 | $381.78 | 429,531.0000 | 29,785,000 | 0.15% | 0.00% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 1805 | $0.00 | 431,336.0000 | 29,785,000 | 0.42% | 0.01% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 895 | $381.78 | 430,441.0000 | 29,785,000 | 0.21% | 0.00% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 2320 | $0.00 | 432,761.0000 | 29,785,000 | 0.54% | 0.01% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 1151 | $381.78 | 431,610.0000 | 29,785,000 | 0.27% | 0.00% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad A Common Stock | 2600 | $0.00 | 434,210.0000 | 29,785,000 | 0.60% | 0.01% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad A Common Stock | 1290 | $381.78 | 432,920.0000 | 29,785,000 | 0.30% | 0.00% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Bio-Rad B Common Stock | 39000 | $117.50 | 4,443,643.0000 | 29,785,000 | 0.89% | 0.13% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | F | Bio-Rad B Common Stock | 25389 | $381.78 | 4,418,254.0000 | 29,785,000 | 0.57% | 0.09% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 2081 | $0.00 | 6,245.0000 | 29,785,000 | 24.99% | 0.01% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 1266 | $0.00 | 2,532.0000 | 29,785,000 | 33.33% | 0.00% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 1805 | $0.00 | 1,805.0000 | 29,785,000 | 50.00% | 0.01% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 2320 | $0.00 | 2,320.0000 | 29,785,000 | 50.00% | 0.01% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Restricted Stock Units | 2600 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.01% |
| Aug. 25, 2023 | SCHWARTZ NORMAN D | Chairman, President, and CEO | M | Non-Qualified Stock Option (right to buy) | 39000 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.13% |
| Aug. 23, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | S | Bio-Rad A Common Stock | 300 | $384.69 | 2,415.7965 | 29,785,000 | 11.05% | 0.00% |
| June 15, 2023 | Crowley Michael | EVP, GBL Commercial Operations | S | Bio-Rad A Common Stock | 500 | $379.39 | 6,040.0000 | 29,785,000 | 7.65% | 0.00% |
| June 6, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | S | Bio-Rad A Common Stock | 17 | $368.49 | 181.0000 | 29,785,000 | 8.75% | 0.00% |
| June 6, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | S | Bio-Rad A Common Stock | 181 | $368.28 | 0.0000 | 29,785,000 | 100.00% | 0.00% |
| April 29, 2023 | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 1000 | $0.00 | 4,112.6151 | 29,785,000 | 32.13% | 0.00% |
| April 29, 2023 | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 346 | $450.79 | 3,766.6151 | 29,785,000 | 8.41% | 0.00% |
| April 29, 2023 | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 1000 | $0.00 | 1,000.0000 | 29,785,000 | 50.00% | 0.00% |
| April 29, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | M | Bio-Rad A Common Stock | 277 | $0.00 | 294.3520 | 29,785,000 | 1596.36% | 0.00% |
| April 29, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | F | Bio-Rad A Common Stock | 96 | $450.79 | 198.3520 | 29,785,000 | 32.61% | 0.00% |
| April 29, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | M | Restricted Stock Units | 277 | $0.00 | 554.0000 | 29,785,000 | 33.33% | 0.00% |
| April 8, 2023 | Daskal Ilan | EVP, Chief Financial Officer | M | Bio-Rad A Common Stock | 700 | $0.00 | 1,736.2680 | 29,785,000 | 67.55% | 0.00% |
| April 8, 2023 | Daskal Ilan | EVP, Chief Financial Officer | F | Bio-Rad A Common Stock | 243 | $466.24 | 1,493.2680 | 29,785,000 | 14.00% | 0.00% |
| April 8, 2023 | Daskal Ilan | EVP, Chief Financial Officer | M | Restricted Stock Units | 700 | $0.00 | 700.0000 | 29,785,000 | 50.00% | 0.00% |
| March 8, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 850 | $159.32 | 4,267.3635 | 29,785,000 | 24.87% | 0.00% |
| March 8, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Bio-Rad A Common Stock | 150 | $215.98 | 4,417.3635 | 29,785,000 | 3.52% | 0.00% |
| March 8, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | S | Bio-Rad A Common Stock | 1000 | $486.08 | 3,417.3635 | 29,785,000 | 22.64% | 0.00% |
| March 8, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | S | Bio-Rad A Common Stock | 746 | $486.89 | 2,671.3635 | 29,785,000 | 21.83% | 0.00% |
| March 8, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Non-Qualified Stock Option (right to buy) | 850 | $0.00 | 0.0000 | 29,785,000 | 100.00% | 0.00% |
| March 8, 2023 | ERNST TIMOTHY S | EVP, General Counsel & Sec | M | Non-Qualified Stock Option (right to buy) | 150 | $0.00 | 2,350.0000 | 29,785,000 | 6.00% | 0.00% |
| Feb. 10, 2023 | RAMALINGAM AJIT | SVP, Chief Accounting Officer | A | Restricted Stock Units | 644 | $0.00 | 644.0000 | 29,785,000 | 9999.99% | 0.00% |